Gapping up
In reaction to strong earnings/guidance:
- N/A
M&A news:
- REN +8.1% (to be acquired by Cimarex (XEC) in a cash and stock transaction valued at $35/share)
Select EU financial related names showing strength:
- PSO +2.2%, LYG +2.2%, ING +0.8%, BCS +0.7%, RBS +0.5%
Other news:
- GOGO +4.8% (prices offering of $215 mln aggregate principal amount of convertible senior notes due 2022)
- AIMT +4.7% (publication of full results of landmark phase 3 PALISADE clinical trial of AR101 in New England Journal of Medicine)
- BB +2.3% (continued strength)
- TSRO +2.1% (continued strength)
- GSK +1% (ViiV Healthcare receives CHMP Positive Opinion for Tivicay EU label update with GEMINI study data for the 2-drug regimen of Tivicay + lamivudine)
- KL +0.9% (announces series of management changes, names David Soares CFO)
Analyst comments:
- VKTX +7.3% (upgraded to Strong Buy from Outperform at Raymond James)
- ICPT +2.3% (upgraded to Outperform from Perform at Oppenheimer)
- PBYI +2.2% (upgraded to Neutral from Sell at Goldman)
- BIG +1.5% (upgraded to Overweight from Neutral at Piper Jaffray)
- DAR +0.7% (upgraded to Overweight from Neutral at JP Morgan)